Clinical Trial Update: Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of Leuvectin for locally recurrent prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuvectin

Snippet

Sponsor: Vical | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED